Published in Clinical, Cosmetic and Investigational Dermatology, a clinical study on Sabinsa’s patented hair serum formulation was found to improve hair fall and thinning.
This patent grant, MX355546, is for a composition comprised of 10% w/w of 1-O-galloyl-β-D-glucose (β-glucogallin). This was specifically isolated from the company’s Emblica officinalis and a concentrate from the company’s liquid endosperm of Cocos nucifera, along with selenopeptides for protecting the dermal papilla cells.
The study was an open-label clinical trial, which evaluated the efficacy and safety of Sabinsa’s hair serum in adult male and female subjects. The serum—a multi-patented composition of amla extract, freeze-dried coconut water, micronutrient selenium, sandalwood and peanut shell extract—was evaluated in 42 subjects for a period of 90 days. Apart from self and dermatological assessment, trichogram instrumentation and software quantitatively assessed hair growth.
A perceivable improvement in hair growth rate and density was observed, while hair fallout and thinning were reduced at the end of 90 days. With continuous application of the test product, a 57% reduction in hair breakage and 81% reduction in hair fallout was observed by a dermatologist, while trichogram analysis revealed significant improvements in hair density and growth.
Previously: Nutrafol’s First Topical: Hair Growth Serum
All subjects reported an overall improvement in hair texture and volume with reduced hair fallout. According to the study, no adverse events were reported. In baseline visits, scalp conditions were noted including, itching, dryness and dandruff, which were resolved after application of the product.
“The effects of hair loss can be emotionally consequential,” said Muhammed Majeed, Ph.D., Sabinsa founder and chairman. “Though herbs and, more recently, herbal extracts have been used in hair care, this combination of ingredients offers a synergistic activity, as each of them has a different mechanism for protecting and nourishing hair follicles.”
The product is currently licensed to Johara Cosmetics but Sabinsa soon plans to open the license to this patented combination to customers worldwide under the trademark AMIFERA.
For more information, contact Sabinsa.